Therapeutic effects of S-allyl-L-cysteine in a mouse endometriosis model and its immunomodulatory effects via regulation of T cell subsets and cytokine expression
S-allyl-L-cysteine (SAC) treatment inhibited endometriotic lesion growth in mice by promoting apoptosis, reducing adhesion, and modulating T cell subsets and cytokine expression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The paper studies whether S-allyl-L-cysteine (SAC), an antioxidant constituent of aged garlic extracts, can treat endometriosis and modulate immune responses in a surgically induced mouse endometriosis model. Mice received oral SAC (30 mg/kg daily) for 28 days, and the authors assessed endometriotic lesion growth histologically, measured adhesion-, apoptosis-, and inflammation-related gene expression by PCR, and used spleen flow cytometry to examine T cell subset changes and cytokine production in spleen and lesions. SAC significantly inhibited lesion growth, promoted apoptosis- and reduced antiadhesion-related gene expression, and altered splenic CD4+ and CD8+ T cell subsets along with inflammatory cytokine production, with the main limitation being reliance on an induced mouse model and the study’s short intervention window. This paper is centrally about endometriosis — it evaluates SAC’s therapeutic and immunomodulatory effects in a mouse endometriosis model.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
13,467 characters
· extracted from
oa-doi-fallback
· 5 sections
· click to expand
Abstract
Methods
Results
Conclusion
References
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (52)
- Apoptosis and the Pathogenesis of Endometriosis via openalex
- Chronic Niche Inflammation in Endometriosis-Associated Infertility: Current Understanding and Future Therapeutic Strategies via openalex
- Clinical immunology<br>Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis via openalex
- Combating endometriosis by blocking proteasome and nuclear factor- B pathways via openalex
- Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model via openalex
- Endometriosis: Diagnosis and Management via openalex
- Endometriosis: Epidemiology, Diagnosis and Clinical Management via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Inflammation and endometriosis via openalex
- Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis via openalex
- Melatonin inhibits endometriosis development by disrupting mitochondrial function and regulating tiRNAs via openalex
- Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis via openalex
- Peritoneal interleukin-10 increases with decrease in activated CD4+ T lymphocytes in women with endometriosis via openalex
- Potential involvement of the immune system in the development of endometriosis via openalex
- Risk factors for postoperative recurrence of ovarian endometriosis: long-term follow-up of 358 women via openalex
- The Origin and Pathogenesis of Endometriosis via openalex
- Therapeutic Approaches of Resveratrol on Endometriosis via Anti-Inflammatory and Anti-Angiogenic Pathways via openalex
- Treatment of pain associated with deep endometriosis: alternatives and evidence via openalex
- W2097972396 via openalex
- W2116663518 via openalex
- W2140041517 via openalex
- W2143515468 via openalex
- W2145753985 via openalex
- W2293830866 via openalex
- W2556335555 via openalex
- W2765194389 via openalex
- W2908873212 via openalex
- W2987139850 via openalex
- W2997912675 via openalex
- W2998057916 via openalex
- W3184777521 via openalex
- W4360980926 via openalex
- W6689513977 via openalex
- W1174588851 via openalex
- W6767670412 via openalex
- W1840158612 via openalex
- W1887756647 via openalex
- W1910985554 via openalex
- W1922580849 via openalex
- W1943303117 via openalex
- W1969922642 via openalex
- W1993178429 via openalex
- W1998806168 via openalex
- W2015984569 via openalex
- W2018994254 via openalex
- W2022939431 via openalex
- W2025852938 via openalex
- W2040170421 via openalex
- W2042144284 via openalex
- W2044973041 via openalex
- W2078450323 via openalex
- W2080592035 via openalex
Cited by (3)
- Low-FODMAP Diet for Gastrointestinal Symptoms in Endometriosis: A Systematic Review 2026
- Carvacrol Shows Potential as a Treatment for Endometriosis with Inflammatory Reaction and Antioxidant Properties, Demonstrated in both In Vivo and In Vitro Studies 2025
- Endometriosis and Ovarian Cancer: Insights from NHANES and Mendelian Randomization Analysis 2025
Source provenance
- europepmc
- last seen: 2026-08-02T06:10:09.037253+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-08-02T06:08:07.733735+00:00